clinical data

MENLO PARK, Calif., August 31, 2026 AN2 Therapeutics, Inc. announced that four abstracts featuring clinical and translational data for...

Pasadena, Calif. – August 30, 2026 Arrowhead Pharmaceuticals presented detailed Phase 3 SHASTA-3 and SHASTA-4 data showing that plozasiran...

Zug, Switzerland & Boston, Mass. – August 28, 2026 CRISPR Therapeutics presented new Phase 1a durability data for CTX310,...

Lexington, Mass. – August 28, 2026 Agenus Inc. announced the publication of mature Phase 1b results evaluating botensilimab (BOT)...

Dublin, Ireland & Bridgewater, N.J. – August 28, 2026 Amarin Corporation announced new post hoc findings from the landmark...

Ashburn, Va. – August 28, 2026 Quoin Pharmaceuticals announced positive interim results from the ongoing Phase 2/3 CL-QRX003-004 study...

Basel, Switzerland – August 28, 2026 Roche announced new two-year results from the Phase IIIb/IV SALWEEN study evaluating Vabysmo®...

Warren, New Jersey, August 24, 2026 PTC Therapeutics, Inc. announced that new clinical and real-world evidence for Sephience™ (sepiapterin)...

Los Angeles, California, USA, August 21, 2026 Allies of Skin has announced the launch of Peptint Tripeptide & Goji...

North Chicago, Illinois, USA, August 21, 2026 AbbVie has announced new clinical, translational and real-world research findings that will...